ERLOGLOB 150

ERLOTINIB TABLETS 150 MG

Indication

Locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR activating mutations, either as I-line or as switch maintenance treatment and stable disease after I-line chemotherapy. Also used for metastatic pancreatic cancer.

Pack

30 Tablets Bottle
Categories: ,

Note: Products are not marketed in countries where it is protected by Patent Law